Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,916 | 16,237 | 21,747 | 20,088 | 19,704 |
| Receivables | 17,579 | 16,341 | 16,906 | 17,477 | 17,589 |
| Inventories | 18,160 | 20,101 | 19,005 | 17,928 | 15,832 |
| Income taxes - deferred | 3,908 | 5,746 | 5,222 | 5,384 | 5,441 |
| TOTAL | $57,563 | $58,425 | $62,880 | $60,877 | $58,566 |
| Non-Current Assets | |||||
| PPE Net | 3,086 | 3,082 | 3,438 | 3,343 | 3,146 |
| Intangibles | 57,845 | 59,076 | 56,231 | 56,774 | 56,600 |
| Other Non-Current Assets | 8,140 | 6,385 | 6,461 | 6,549 | 6,485 |
| TOTAL | $69,071 | $68,543 | $66,130 | $66,666 | $66,231 |
| Total Assets | $126,634 | $126,968 | $129,010 | $127,543 | $124,797 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,959 | 5,265 | 5,367 | 5,725 | 4,925 |
| Accrued Expenses | 3,574 | 4,162 | 4,162 | 3,989 | 5,271 |
| Other current liabilities | 543 | 428 | 318 | 663 | 649 |
| TOTAL | $9,559 | $10,215 | $10,344 | $10,913 | $11,296 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,300 | 16,305 | 17,107 | 17,107 | 18,009 |
| Deferred Revenues | 483 | 360 | 497 | 532 | 451 |
| Other Non-Current Liabilities | 4,907 | 3,491 | 3,727 | 4,346 | 4,290 |
| TOTAL | $21,576 | $20,776 | $21,857 | $22,464 | $23,253 |
| Total Liabilities | $31,135 | $30,991 | $32,201 | $33,377 | $34,549 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,753 | 28,499 | 28,489 | 28,424 | 28,389 |
| Common Shares | 362 | 362 | 362 | 361 | 361 |
| Retained earnings | -79,630 | -80,368 | -80,397 | -81,766 | -83,442 |
| Other shareholders' equity | -5,390 | -3,229 | -1,392 | -1,709 | -3,564 |
| TOTAL | $95,499 | $95,977 | $96,809 | $94,166 | $90,248 |
| Total Liabilities And Equity | $126,634 | $126,968 | $129,010 | $127,543 | $124,797 |